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Abstract Administration of angiotensin II to rats decreases
renal expression of klotho, an aging-related gene, and also
causes abnormal iron deposition in renal cells. Here we have
examined the e¡ects of iron overload and iron chelation on renal
expression of klotho in untreated rats and rats treated with
angiotensin II. Administration of iron^dextran caused a down-
regulation of klotho expression, and iron chelation suppressed
the angiotensin II-induced downregulation of this gene. In addi-
tion, a free radical scavenger (T-0970), which e¡ectively de-
creased plasma levels of 8-epi-prostaglandin F2K (8-epi-
PGF2K), suppressed angiotensin II-induced downregulation of
klotho. Collectively, these ¢ndings suggest that abnormal iron
metabolism and increased oxidative stress are involved in the
mechanism of angiotensin II-mediated modulation of klotho ex-
pression.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The murine klotho gene was identi¢ed as a suppressor of
multiple aging phenotypes similar to age-related diseases in
humans, such as atherosclerosis, cognition impairment, em-
physema, and short lifespan [1^3]. Interestingly, despite the
fact that various actions of the klotho gene have been sug-
gested from mouse models of klotho de¢ciency, this gene is
expressed almost exclusively in the renal tubular cells. Recent
studies have suggested that a human functional variant of
klotho is associated with both reduced human longevity [4]
and an occult coronary artery disease that is independent of
other confounding factors [5], which may indicate that klotho
gene expression also has a role in the development of the
aging-related phenotypes in humans. Renal expression of klo-
tho gene is downregulated in patients with severe renal dys-
function [6] and in animals in response to sustained circula-
tory stress [7] and metabolic disorders [8] ; however, the
mechanism underlying the modulation of klotho expression
in vivo still remains largely unclear.
We have recently shown that continuous administration of
angiotensin II, but not catecholamines, decreases renal klotho
expression in rats, which may in turn have a role in the aug-
mentation of angiotensin II-induced renal injury [9]. In anoth-
er set of experiments, we found that administration of angio-
tensin II to rats causes apparent deposition of iron in the
kidney [10]. In the present study, we have investigated
whether iron chelation can inhibit angiotensin II-induced
downregulation of renal klotho expression, and whether iron
overload can decrease klotho expression.
2. Materials and methods
2.1. Animal models
Angiotensin II was continuously infused into male Sprague^Dawley
rats by subcutaneous implantation of an osmotic minipump (Alzet
model 2001; Alza Pharmaceutical) as described previously [11].
Brie£y, Val5-angiotensin II (Sigma) was infused at a dose of 0.7
mg/kg/day for 7 days. Norepinephrine (Sigma) was infused into rats
at a rate of 2.8 mg/kg/day. In some experiments, rats were given daily
subcutaneous injections of the iron chelator, deferoxamine (DFO, a
kind gift from Novartis) at a dose of 200 mg/kg/day. Iron overload
was induced by an intraperitoneal injection of an iron^dextran com-
plex (a kind gift from Teikoku Hormone Mfg) at a dose of 240 mg of
elemental iron/kg on days 0, 2, 4, and 6 of angiotensin II infusion.
In some experiments, a new free radical scavenger, T-0970 [12] (a
kind gift from Tanabe Seiyaku), was given orally at a dose of 10 mg/
kg/day. Systolic blood pressure was measured in conscious rats by
tail-cu¡ plethysmography (Ueda Seisakusyo). Concentrations of plas-
ma and urine creatinine were measured by the Ja¡e reaction, and
urinary protein was measured by the pyrogallol red-molybdate protein
dye-binding method (SRL).
2.2. Northern blot analysis
Total RNA was obtained using Isogen (Wako), and mRNA was
subsequently isolated using oligotex-dT30 (Roche Diagnostics).
Mouse klotho cDNA was labeled with [K-32P]dCTP (Amersham Life
Sciences) using commercial kits (Nippon Gene). Hybridized bands
were visualized and quanti¢ed using a bio-imaging analyzer (BAS
2000; Fuji Photo Film), and band density was normalized to the
intensity of a band corresponding to glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) mRNA.
2.3. Western blot analysis
Polyclonal antibodies against mouse Klotho (a kind gift from Kyo-
wa Hakko) and monoclonal antibody against L-actin (Sigma) were
used at dilutions of 1/4000 [9] and 1/2000, respectively. The enhanced
chemiluminescence (ECL) Western blotting system (Amersham Life
Sciences) was used for detection. Band intensity was calculated and
is expressed as a percentage of the control value.
2.4. Measurement of plasma levels of 8-epi-prostaglandin F2K
(8-epi-PGF2K )
Plasma free 8-epi-PGF2K was measured by liquid chromatography-
electrospray ionization-mass spectrometry (LC-ESI-MS) as described
elsewhere [13]. Brie£y, a four-sector type MStation 700 tandem mass
spectrometer (JEOL) equipped with an ESI source was used in the
negative ion-selected ion-monitoring mode. Quasi-molecular ions (de-
protonated ions), m/z 353.24 and m/z 357.26 for 8-epi-PGF2K and the
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internal standard, respectively, were each monitored for 500 ms each
in the selected ion-monitoring mode at a mass spectral resolution of
1500.
2.5. Statistical analysis
Data are expressed as the meanNS.E.M. We used analysis of var-
iance (ANOVA) followed by a multiple comparison test to compare
the initial data, before expressing the results as a percentage of the
control value using the statistical analysis software StatView. A value
of P6 0.05 was considered to be statistically signi¢cant.
3. Results
3.1. E¡ect of iron overload on renal klotho expression
Iron overload did not signi¢cantly increase the blood pres-
sure of rats (131N 3 mmHg, n=10) as compared to untreated
control rats (131N 3 mmHg, n=6). In the kidney of rat sub-
jected to iron overload, expression of klotho mRNA was
downregulated (Fig. 1) to a similar extent as in rats given a
hypertensive dose of angiotensin II (192N 4 mmHg, n=10).
Concomitant administration of iron^dextran and angiotensin
II did not have additive e¡ects on klotho expression. When
rats were subjected to iron overload and norepinephrine at a
dose that exerted hypertensive e¡ects comparative to those of
angiotensin II, downregulation of klotho was also observed.
However, downregulation of klotho was not observed in rats
given norepinephrine alone. Western blot analysis showed
that iron overload also decreased the renal expression of Klo-
tho protein (Fig. 1).
3.2. E¡ects of iron chelation and a free radical scavenger on
angiotensin II-induced downregulation of klotho gene
Treatment of angiotensin II-infused rats with deferoxamine,
which did not signi¢cantly a¡ect blood pressure (196N 7
mmHg, n=9), inhibited angiotensin II-induced downregula-
tion of both klotho mRNA and Klotho protein (Fig. 2A,
B). Treatment of the angiotensin II-infused rats with a free
radical scavenger, T-0970, which again did not signi¢cantly
a¡ect blood pressure (200N 9 mmHg, n=11), also inhibited,
albeit partially, angiotensin II-induced downregulation of the
klotho gene (Fig. 2A, C). Histological analysis showed that
treating angiotensin II-infused rats with deferoxamine [10],
but not with T-0970 (unpublished data), inhibited iron depo-
sition in the renal tubular epithelial cells.
3.3. In vivo oxidative stress in rats treated with various agents
We investigated the extent of in vivo oxidative stress by
measuring plasma levels of 8-epi-PGF2K. Angiotensin II ad-
ministration increased plasma levels of 8-epi-PGF2K as we
have reported previously [14]. Iron overload also increased
plasma levels of 8-epi-PGF2K to levels similar to those induced
by angiotensin II (Fig. 3). The angiotensin II-induced increase
in plasma levels of 8-epi-PGF2K was blocked partially by de-
feroxamine, and completely by T-0970, which veri¢ed the use
of T-0970 as a free radical scavenger in our system.
3.4. E¡ect of radical scavenger on the renal function and extent
of proteinuria
We have previously demonstrated that the induction of
klotho expression by adenovirus-mediated gene transfer amel-
iorates angiotensin II-induced increase in proteinuria [9]. We
have also showed that the treatment of angiotensin II-infused
rats with deferoxamine suppresses the proteinuric e¡ects of
angiotensin II [10]. These results, together with the ¢ndings
of the present study, suggested that the proteinuric e¡ects of
Fig. 1. Expression of klotho in the kidney after rats were treated with angiotensin II, norepinephrine, and iron^dextran. A: Representative
Northern blot. B: Summary of the Northern blot data from four to six animals in each group. C: Representative Western blot. D: Summary
of the Western blot data from four to six animals in each group. *P6 0.05 and 2P6 0.01 versus untreated rats.
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angiotensin II might be augmented by the downregulation of
klotho expression induced by this octapeptide. Thus, we mea-
sured the extent of proteinuria and creatinine clearance in the
rats treated with the radical scavenger. As expected, T-0970
suppressed the angiotensin II-induced increase in proteinuria,
but did not a¡ect the angiotensin II-induced decrease in crea-
tinine clearance (Fig. 4).
4. Discussion
In the present study, we have shown that iron overload
decreased renal expression of the klotho gene at both the
mRNA and the protein level, and that iron chelation sup-
pressed the angiotensin II-induced downregulation of klotho.
These ¢ndings suggest the mechanisms of angiotensin II-in-
duced downregulation of klotho may include abnormal iron
metabolism in the kidney elicited by angiotensin II adminis-
tration. Furthermore, as treating the angiotensin II-infused
rats with a free radical scavenger suppressed the angiotensin
II-induced downregulation of klotho, an increased production
of reactive oxygen species may also play some role in the
altered klotho expression caused by angiotensin II administra-
tion. Iron is known to enhance organ damage induced by
oxidants by catalyzing the Fenton reaction to generate highly
toxic hydroxyl radicals, thus it is possible that the angiotensin
II-induced deposition of renal iron may decrease klotho by
inducing oxidative stress.
Although the phenotypic e¡ects and cardiovascular func-
tions of the klotho gene have been extensively studied in ani-
mal models, recent studies suggest that this gene may also
have a considerable physiological signi¢cance in humans be-
cause of the possible association between a human variant of
klotho and both reduced human longevity [4] and susceptibil-
ity to atherosclerotic diseases [5]. As klotho expression has
been shown to be regulated in humans [6], it is important to
clarify the mechanism responsible for this regulation.
Expression of klotho is downregulated in animal models of
hemodynamic and metabolic disorders, such as the spontane-
ously hypertensive rat, the deoxycorticosterone acetate-salt
hypertensive rat, and the Otsuka Long^Evans Tokushima
fatty rat [7]. Drug interventions that ameliorate hemodynamic
and metabolic abnormalities augment the renal expression of
Fig. 2. E¡ects of an iron chelator and a free radial scavenger on angiotensin II-induced klotho downregulation. A: Representative Northern
blot. B: Summary of the Northern blot data from four to six animals in each group. C: E¡ect of deferoxamine on the angiotensin II-induced
decrease in Klotho protein. Representative Western blot. D: Summary of the Western blot data from four to six animals in each group. E: Ef-
fect of the free radical scavenger T-0970 on the angiotensin II-induced decrease in Klotho protein. Representative Western blot. F: Summary
of the Western blot data from four to six animals in each group. *P6 0.05 and 2P6 0.01 versus untreated rats, and VP6 0.05 and 4P6 0.01
versus angiotensin II-treated rats.
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klotho in some genetically altered animal models, which sug-
gests that, in addition to the genetic background, factors in-
volved in hemodynamic and metabolic processes may indeed
have a role in the regulation of klotho expression [15]. Further
study of the pathway that regulates klotho expression is not
easy, however, because to date no established cultured renal
cell lines are reported to express this gene.
In the present study, we have shown that a free radical
scavenger suppressed the angiotensin II-induced downregula-
tion of klotho, which suggests that an increase in systemic
oxidative stress may decrease renal klotho expression. How-
ever, norepinephrine infusion, which also increases plasma
levels of 8-epi-PGF2K [14], did not decrease renal expression
of klotho. Thus, an increase in systemic oxidative stress may
not account, or may not be su⁄cient, for the angiotensin II-
induced decrease in renal expression of klotho.
In the last part of the present study, we examined the e¡ects
of a free radical scavenger on the renal function and on renal
excretion of protein in the angiotensin II-infused rats and
found that the radical scavenger inhibited the proteinuric ef-
fects of angiotensin II. This observation is consistent with the
notion that angiotensin II-induced renal damage will be ame-
liorated by increased expression of klotho. Whether previously
observed anti-proteinuric e¡ects of antioxidants [16,17] are
mediated, or at least accompanied, by the augmentation of
renal klotho expression should be investigated in future stud-
ies.
In conclusion, iron overload decreased renal expression of
klotho at both the mRNA and the protein level, and iron
chelation suppressed the angiotensin II-induced downregula-
tion of this gene, suggesting that alteration in iron metabolism
may have a role in the angiotensin II-induced downregulation
of renal klotho expression. Furthermore, a free radical scav-
enger also suppressed the angiotensin II-induced downregula-
tion of klotho, supporting the involvement of an increased
production of reactive oxygen species in this process.
Acknowledgements: This work was supported by Grants in Aid for
Scienti¢c Research from the Ministry of Education, Science, and Cul-
ture of Japan (Grant 13671098), and Novartis Foundation for Ger-
ontological Research (N.I.). We are highly appreciative of Kyoko
Furuta for her excellent technical assistance and of Dr. Noriko Oha-
shi (Discovery Research Laboratory, Tanabe Seiyaku) for the assay
for plasma levels of 8-epi-PGF2K.
References
[1] Kuro-o, M. et al. (1997) Nature 390, 45^51.
[2] Suga, T. et al. (2000) Am. J. Respir. Cell Mol. Biol. 22, 26^
33.
[3] Nagai, T., Yamada, K., Kim, H.C., Kim, Y.S., Noda, Y., Imura,
A., Nabeshima, Y. and Nabeshima, T. (2003) FASEB J. 17, 50^
52.
[4] Arking, D.E. et al. (2002) Proc. Natl. Acad. Sci. USA 99, 856^
861.
[5] Arking, D.E., Becker, D.M., Yanek, L.R., Fallin, D., Judge,
D.P., Moy, T.F., Becker, L.C. and Dietz, H.C. (2003) Am. J.
Hum. Genet. 72, 1154^1161.
[6] Koh, N. et al. (2001) Biochem. Biophys. Res. Commun. 280,
1015^1020.
[7] Aizawa, H. et al. (1998) Biochem. Biophys. Res. Commun. 249,
865^871.
[8] Nagai, R., Saito, Y., Ohyama, Y., Aizawa, H., Suga, T., Naka-
mura, T., Kurabayashi, M. and Kuroo, M. (2000) Cell. Mol. Life
Sci. 57, 738^746.
[9] Mitani, H. et al. (2002) Hypertension 39, 838^843.
[10] Ishizaka, N. et al. (2002) Lab. Invest. 82, 87^96.
[11] Ishizaka, N., de Leon, H., Laursen, J.B., Fukui, T., Wilcox, J.N.,
De Keulenaer, G., Griendling, K.K. and Alexander, R.W. (1997)
Circulation 96, 1923^1929.
Fig. 4. Renal function and proteinuria in rats treated with adminis-
tration of angiotensin II and a free radical scavenger. A: Creatinine
clearance. B: Proteinuria. Data from ¢ve to eight plasma or urine
samples are summarized in the table. CCr indicates creatinine clear-
ance. *P6 0.01 vs. untreated control.
Fig. 3. Plasma levels of 8-epi-PGF2K in the rats treated with angio-
tensin II, iron^dextran, deferoxamine, and free radical scavenger.
Number of each group was written in parentheses. *P6 0.05 versus
untreated rats and 2P6 0.05 versus angiotensin II-treated rats.
*P6 0.05 and 2P6 0.01 versus untreated rats, and VP6 0.05 and
4P6 0.01 versus angiotensin II-treated rats.
FEBS 27582 27-8-03
K. Saito et al./FEBS Letters 551 (2003) 58^62 61
[12] Suzumura, K., Hashimura, Y., Kubota, H., Ohmizu, H. and
Suzuki, T. (2000) Free Radic. Res. 32, 255^264.
[13] Ohashi, N. and Yoshikawa, M. (2000) J. Chromatogr., in press.
[14] Aizawa, T., Ishizaka, N., Usui, S., Ohashi, N., Ohno, M. and
Nagai, R. (2002) Hypertension 39, 149^154.
[15] Yamagishi, T. et al. (2001) Hypertens. Res. 24, 705^709.
[16] Sanaka, T., Nakano, Y., Nishimura, H., Shinobe, M., Higuchi,
C., Omata, M., Nihei, H. and Sugino, N. (1997) Nephron 76,
315^322.
[17] Milner, L.S., Wei, S.H., Stohs, S.J., Eldeen, Z.M. and Houser,
M.T. (1992) Nephron 62, 192^197.
FEBS 27582 27-8-03
K. Saito et al./FEBS Letters 551 (2003) 58^6262
